Xueting Yao Selected Research

Leflunomide (Arava)

8/2019	A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus.
7/2019	Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xueting Yao Research Topics

Disease

8	COVID-19 04/2021 - 01/2020
6	Type 2 Diabetes Mellitus (MODY) 11/2023 - 08/2018
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2021 - 07/2019
2	Rheumatoid Arthritis 04/2021 - 08/2019
2	Neoplasms (Cancer) 01/2021 - 03/2019
2	Malaria 01/2020 - 01/2020
1	Duodenal Ulcer (Curling's Ulcer) 05/2024
1	Obesity 06/2023
1	Heart Failure 01/2023
1	Body Weight (Weight, Body) 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Foreign Bodies (Foreign Body) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Critical Illness (Critically Ill) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Brain Injuries (Brain Injury) 03/2019

Drug/Important Bio-Agent (IBA)

6	Chloroquine (Aralen)FDA LinkGeneric 04/2021 - 01/2020
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 01/2020
4	SodiumIBA 05/2024 - 07/2019
3	GlucokinaseIBA 11/2023 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2021
2	Phosphates (Orthophosphate)IBA 04/2021 - 07/2020
2	chloroquine diphosphate FDA LinkGeneric 07/2020 - 01/2020
2	Leflunomide (Arava)FDA LinkGeneric 08/2019 - 07/2019
2	teriflunomideIBA 08/2019 - 07/2019
2	imigliptinIBA 11/2018 - 08/2018
1	Proton Pump InhibitorsIBA 05/2024
1	TabletsIBA 05/2024
1	Anesthetics (Anesthetic Agents)IBA 06/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	SymportersIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	EnzymesIBA 01/2022
1	olverembatinibIBA 01/2022
1	bcr-abl Fusion ProteinsIBA 01/2022
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2022
1	Cytochrome P-450 CYP3AIBA 01/2022
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022
1	Cytochrome P-450 CYP2C9IBA 01/2022
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 04/2021
1	zanubrutinibIBA 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2021
1	Midazolam (Versed)FDA LinkGeneric 01/2021
1	Therapeutic UsesIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	QuercetinIBA 01/2021
1	artenimol (dihydroartemisinin)IBA 11/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Sulfates (Sulfates, Inorganic)IBA 01/2020
1	Proto-Oncogene Proteins B-rafIBA 03/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2018
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 08/2018

Therapy/Procedure

1	Therapeutics 03/2019